MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Hemichorea-hemiballismus following treatment of Intracranial tuberculomas and tuberculous meningitis

    A. Singh, N. Bansal, S. Shivangi, R. Gupta, J. Singhvi, J. Kaur (Mohali, India)

    Objective: To present a case of right-sided hemichorea-hemiballismus that occurred following treatment of intracranial tuberculomas and tuberculous meningitis Background: A 56-year-old lady presented in the…
  • 2022 International Congress

    Safinamide adherence: the experience of the movement disorder unit of Trieste.

    M. Catalan, M. Liccari, V. Tommasini, L. Antonutti, P. Manganotti (Trieste, Italy)

    Objective: Describe the clinical experience with Safinamide and assess the patients’ adherence to this treatment in the movement disorders centre of Trieste-Italy. Background: Safinamide (Xadago®)…
  • 2022 International Congress

    Beliefs about Tourette Syndrome in Adolescent Patients with Tics

    J. Frey, T. Tholanikunnel, L. Kugler, M. Wajid, H. Simpson, I. Malaty (Gainesville, USA)

    Objective: To explore information resources and individual perceptions of causes and modifiers of Tourette Syndrome (TS) and tic disorders. Background: The development of tics is…
  • 2022 International Congress

    Body Image Scale in Functional Movement Disorders; A Comparative Study

    M. Balal, M. Demirkiran (Adana, Turkey)

    Objective: Objective: The aim of this study is to compare the BSI in patients with functional movement disorders and healthy volunteers. Background: Background: Functional movement…
  • 2022 International Congress

    Single-cell characterization of patient midbrain tissue reveals tissue remodeling and glial activation in Parkinson’s disease

    S. Smajic, C. Prada-Medina, Z. Landoulsi, J. Ghelfi, S. Delcambre, C. Dietrich, J. Jarazo, J. Henck, S. Balachandran, S. Pachchek, C. Morris, P. Anotny, B. Timmermann, S. Sauer, S. Pereira, J. Schwamborn, P. May, M. Spielmann (Esch-sur-Alzette, Luxembourg)

    Objective: We aim to characterize the contribution of each midbrain cell type to PD pathology, and to identify cell types associated with genetic PD-risk variants.…
  • 2022 International Congress

    EPIDEMIOLOGY OF FUNCTIONAL MOVEMENT DISORDERS

    B. Yardimci Kara, N. Oksuz Gurlen, O. Dogu (Mersin, Turkey)

    Objective: Our study aims to report the frequency of patients with FMD and to describe their demographic and clinical data. The second aim of our…
  • 2022 International Congress

    Pilot study to investigate the use of in-clinic sensing to identify optimal stimulation parameters for deep brain stimulation therapy in Parkinson’s disease

    S. Lewis, S. Ojemann, D. Kramer, L. Hirt, E. Radcliffe, M. Case, A. Becker, R. Raike, J. Thompson, D. Kern (Boulder, USA)

    Objective: Compare the use of in-clinic sensing functionality and standard of care monopolar review for identifying optimal settings of a deep brain stimulation (DBS) in…
  • 2022 International Congress

    Sigma Absolute Spectral Power is Associated with Depression in Parkinson’s Disease

    A. Memon, C. Catiul, Z. Irwin, J. Pilkington, A. Joop, R. Memon, K. Wood, G. Cutter, S. Miocinovic, A. Amara (Birmingham, USA)

    Objective: This cross-sectional study investigated the relationship between depression and sigma absolute spectral power (9-15 Hz) in the frequency range of sleep spindles during non-rapid…
  • 2022 International Congress

    Effect of CDNF in a novel combination stressor model of Parkinson’s disease

    A. Singh, A. Panhelainen, M. Voutilainen (Helsinki, Finland)

    Objective: In this study, our first aim was to develop a model for Parkinson's disease (PD) that would exhibit the alpha-synuclein (αSyn) aggregation pathology and…
  • 2022 International Congress

    Two cases of severe generalized dystonia in IRF2BPL and response to treatment

    M. Hull, M. Parnes (Houston, USA)

    Objective: We describe two patients who presented with progressive, generalized dystonia and associated neurodevelopmental regression in early childhood found to have pathogenic variants in IRF2BPL.…
  • « Previous Page
  • 1
  • …
  • 663
  • 664
  • 665
  • 666
  • 667
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley